Dr. Reddy's Laboratories
148 hedge funds and large institutions have $870M invested in Dr. Reddy's Laboratories in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 51 reducing their positions, and 22 closing their positions.
9% more capital invested
Capital invested by funds: $796M → $870M (+$74.7M)
1.36% more ownership
Funds ownership: 63.2% → 64.56% (+1.4%)
3% less funds holding
Funds holding: 152 → 148 (-4)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
14% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 51
29% less call options, than puts
Call options by funds: $227K | Put options by funds: $321K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$10.5M |
| 2 |
Renaissance Technologies
New York
|
+$9.1M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$8.04M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.66M |
| 5 |
AG
Aperio Group
Sausalito,
California
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.67M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.92M |
| 3 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
-$7.42M |
| 4 |
JP Morgan Chase
New York
|
-$4.54M |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
-$3.35M |
RDY Hedge Fund Activity: Q4 2019 in Review
148 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2019, worth a combined $870M — up 9.4% from $796M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of RDY and 19 opened new positions — a net loss of 3 holders — while 51 trimmed existing stakes and 44 added.
The largest buyer was Goldman Sachs, adding an estimated $10.5M. The largest seller was Wellington Management Group, cutting an estimated $9.67M.
- 148 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2019, down from 152 in Q3 2019.
- Funds reported $870M of Dr. Reddy's Laboratories stock for Q4 2019, up 9.4% quarter-over-quarter.
- 19 funds opened new Dr. Reddy's Laboratories positions in Q4 2019 and 22 closed out, a net change of -3 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2019 was Goldman Sachs, an estimated $10.5M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2019 was Wellington Management Group, an estimated $9.67M sold.
Based on aggregated 13F filings for Q4 2019.